The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual ...
Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results